まとめ
化学療法にもかかわらず,肺結核患者の持続的な発熱は,併発性セプチセミアを示す可能性があります. 血液培養は,白血球症がない場合でも,これらの症例における細菌感染症の特定に不可欠です.
科学分野:
- 感染症 感染症は感染症です.
- 肺内医学 肺内医学 肺内医学
- 微生物学 微生物学とは
背景:
- 肺結核 (TB) の管理には,通常,化学療法が含まれます.
- 発熱は,活性結核の一般的な症状です.
- 化学療法は,発熱を含む症状を緩和することを目的としています.
研究 の 目的:
- 化学療法を受けている肺結核患者の持続熱の原因を調査する.
- この患者グループにおける併発性セプチセミアの発生率と種類を決定する.
- 治療に反応しない発熱性結核患者の血液培養の診断価値を評価する.
主な方法:
- 細菌学的に確定した肺結核と絶え間ない発熱を患った10人の患者の遡及的分析.
- バクテリアの識別 (グラム陽性およびグラム陰性) のための血液培養結果のレビュー.
- 血液培養の発見と唾液と尿培養の相関,白血球症と超感染の放射線徴候の評価.
主要な成果:
- 10人の患者全員で,化学療法による熱は変化しませんでした.
- 血液培養は10人の患者全員で陽性であった:グラム陽性6人,グラム陰性4人.
- 6人の患者の唾液と血液に,また2人の患者の尿と血液にコンコンダントな生物が見つかりました.
- 白血球細胞症と超感染のX線写真の証拠は存在しない.
結論:
- 化学療法で治療された肺結核患者の持続的な発熱は,併発性セプチセミアの調査を正当化します.
- 血液培養は,白血球症に関係なく,発熱性結核患者の同時発生の血流感染症の診断に不可欠です.
- セプチセミアの早期発見は,複雑な結核病症例における適切な管理と改善された患者のアウトカムに不可欠です.
さらに関連する動画
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
10:24Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Published on: May 22, 2026
関連する概念動画
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...